Effect of Ocimum sanctum (tulsi) on glycemic control and lipid profile in type 2 diabetes: a randomised placebo-controlled crossover trial
Agrawal P, Rai V, Singh RB
Published in International Journal of Clinical Pharmacology and Therapeutics
Methodology
Randomised placebo-controlled single-blind crossover trial of tulsi leaf powder 2.5 g daily in patients with non-insulin-dependent diabetes
Key Findings
Fasting blood glucose fell 17.6% and postprandial glucose 7.3% during tulsi treatment relative to placebo periods.
Conclusions
Tulsi leaf powder produced modest glucose reductions in type 2 diabetes.
Limitations
Older trial; single-blind; small sample; crude leaf powder.
Supplements Studied
Fasting blood glucose fell 17.6% and postprandial glucose 7.3% during tulsi treatment.
Outcomes Measured
Fasting blood glucose fell 17.6% and postprandial glucose 7.3% during tulsi treatment relative to placebo periods.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.